Literature DB >> 14772553

TREATMENT of pulmonary tuberculosis with streptomycin and para-aminosalicylic acid; a Medical Research Council investigation.

.   

Abstract

Entities:  

Keywords:  PARA-AMINOSALICYLIC ACID; STREPTOMYCIN; TUBERCULOSIS, PULMONARY-ANTIBIOTIC AND CHEMOTHERAPY

Mesh：

Substances：

Year:  1950        PMID： 14772553      PMCID： PMC2039351     

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  23 in total

1.  Tuberculosis control: challenges of an ancient and ongoing epidemic.

Authors:  Kristin J Cummings
Journal:  Public Health Rep       Date:  2007 Sep-Oct       Impact factor: 2.792

2.  Barriers to reaching the targets for tuberculosis control: multidrug-resistant tuberculosis.

Authors:  Kai Blöndal
Journal:  Bull World Health Organ       Date:  2007-05       Impact factor: 9.408

Review 3.  The pharmacokinetics of para-aminosalicylic acid and its relationship to efficacy and intolerance.

Authors:  Ahmed A Abulfathi; Peter R Donald; Kim Adams; Elin M Svensson; Andreas H Diacon; Helmuth Reuter
Journal:  Br J Clin Pharmacol       Date:  2020-06-21       Impact factor: 4.335

4.  Converting cancer therapies into cures: lessons from infectious diseases.

Authors:  Michael S Glickman; Charles L Sawyers
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

Review 5.  The chemotherapy of tuberculosis: past, present and future.

Authors:  D Mitchison; G Davies
Journal:  Int J Tuberc Lung Dis       Date:  2012-06       Impact factor: 2.373

Review 6.  New drugs and regimens for treatment of TB.

Authors:  Eric Leibert; William N Rom
Journal:  Expert Rev Anti Infect Ther       Date:  2010-07       Impact factor: 5.091

7.  Dose regimen of para-aminosalicylic acid gastro-resistant formulation (PAS-GR) in multidrug-resistant tuberculosis.

Authors:  Yves Kibleur; Hervé Brochart; Hendrik S Schaaf; Andre H Diacon; Peter R Donald
Journal:  Clin Drug Investig       Date:  2014-04       Impact factor: 2.859

Review 8.  Tuberculosis: drug resistance, fitness, and strategies for global control.

Authors:  Erik C Böttger; Burkhard Springer
Journal:  Eur J Pediatr       Date:  2007-11-07       Impact factor: 3.183

Review 9.  Treatment of active pulmonary tuberculosis in adults: current standards and recent advances. Insights from the Society of Infectious Diseases Pharmacists.

Authors:  Ronald G Hall; Richard D Leff; Tawanda Gumbo
Journal:  Pharmacotherapy       Date:  2009-12       Impact factor: 4.705

Review 10.  Outwitting evolution: fighting drug-resistant TB, malaria, and HIV.

Authors:  Daniel E Goldberg; Robert F Siliciano; William R Jacobs
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.